Oka S, Holohan V, Shirasaka T, Choi JY, et al. Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96. HIV Med 2023 Dec 26. doi: 10.1111/hiv.13588.
PMID: 38147871